DORNIER UROWAVE MICROWAVE THERMOTHERAPY SYSTEM

FDA Premarket Approval P970044

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

This device is indicated as a non-surgical treatment alternative to transurethral resection of the prostate (turp) for the treatment of symptomatic benign prostatic hyperplasia (bph) in men with prostatic lengths between 30 mm and 55 mm.

DeviceDORNIER UROWAVE MICROWAVE THERMOTHERAPY SYSTEM
Generic NameSystem, Hyperthermia, Rf/microwave (benign Prostatic Hyperplasia),thermotherapy
ApplicantDornier MedTech America, Inc.
Date Received1997-09-08
Decision Date1998-05-29
Notice Date1998-06-23
PMAP970044
SupplementS
Product CodeMEQ 
Docket Number98M-0403
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product No
Applicant Address Dornier MedTech America, Inc. 1155 Roberts Blvd. kennesaw, GA 30144

Supplemental Filings

Supplement NumberDateSupplement Type
P970044Original Filing
S003 1999-02-02 Normal 180 Day Track
S002 1998-06-30 Real-time Process
S001 1998-06-15 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.